Sonoma Eye 2018 – Foster Ophthalmic Immunology Society

Dr. Novack presented two oral papers at Sonoma Eye 2018, the second annual event held by the Foster Ophthalmic Immunology Society.  One invited presentation was a brief summary of his 30-year perspective on how to evaluate a potential new therapy.  The other dealt with the issue of drop size in ophthalmic medications – is it an issue or a non-issue.  He had previously published on this issue. The meeting was a small, potent gathering of colleagues, allowing the opportunity to scientific interaction ala ARVO in the Sarasota days of the last century.


Gary D. Novack at Sonoma Eye 2018





Dry Eye Workshop II (DEWS II) report published in The Ocular Surface

The Dry Eye Workshop II (DEWS II) report, sponsored by the Tear Film and Ocular Surface Society, has now been published in the July 2017 issue of The Ocular Surface.  There is an introduction, and 10 sub-committee reports, including the Clinical Trials and Regulatory Sub-Committee report of which Dr. Novack was the chair.  This represents over 2 years work by 125+ worldwide researchers and clinicians.  It supplants the 2007 report with the latest review of Dry Eye research. #TFOSDEWSII @aao_ophth

PharmaLogic has a new logo!

Pharma Logic

After more than 25 years of providing service, PharmaLogic has updated our logo.  We’ve decided to incorporate an ocular theme.  This is certainly because of our extensive work in developing novel therapies for ophthalmic disease.  However, as evidenced by our track record, we also work in dermatology, neurology and other therapeutic areas.  Further, this new logo conveys our ‘vision’ – a unique integrative approach to provide the optimal path forward for our clients in achieving their goals.  We look forward to continuing to help our clients in developing novel therapies.